Zimmer Partners’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-800
Closed -$279K 85
2017
Q2
$279K Buy
+800
New +$279K 0.01% 81